The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126594431 12659443 1 I 20160809 20160817 20160817 EXP MX-JNJFOC-20160808419 JANSSEN ARROYO JARAMILLO SE, SERRANO L, FERREIRA HA. EFFECTIVENESS AND SAFETY WITH BIOLOGIC AGENTS IN PATIENTS WITH PSORIASIS. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2016;30:91. 0.00 Y 0.00000 20160817 OT MX MX

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126594431 12659443 1 PS INFLIXIMAB, RECOMBINANT INFLIXIMAB 1 Intravenous (not otherwise specified) U U 103772 LYOPHILIZED POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126594431 12659443 1 Psoriasis

Outcome of event

Event ID CASEID OUTC COD
126594431 12659443 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126594431 12659443 Fungal infection
126594431 12659443 Gastroenteritis
126594431 12659443 Immune thrombocytopenic purpura
126594431 12659443 Latent tuberculosis
126594431 12659443 Pyrexia
126594431 12659443 Upper respiratory tract infection
126594431 12659443 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found